Inhibition of IRE1 #945; RNase activity modulates the secretome of Triple Negative Breast Cancer cells and enhances the effectiveness of chemotherapy.

SUSAN LOGUE

Inhibition of IRE1 #945; RNase activity modulates the secretome of Triple Negative Breast Cancer cells and enhances the effectiveness of chemotherapy.

SUSAN LOGUE

Molecular Biosciences

Research output: Contribution to conference (Published) › Poster

Original language	English (Ireland)
Publication status	Published - 1 Jan 2017
Event	ER Stress, Autophagy & Immune System. 2017 - Duration: 26 Jan 2017 → …

Conference

Conference	ER Stress, Autophagy & Immune System. 2017
Period	26/01/17 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Authors (Note for portal: view the doc link for the full list of authors)

Authors
Susan E Logue, Patricia Cleary, Eoghan McGrath, Katarzyna Mnich, Stephanie Green, John Patterson, Richard Jäger and Afshin Samali

Cite this

@conference{4758af7b58834722873ae422bf4d7e53,

title = "Inhibition of IRE1 \#945; RNase activity modulates the secretome of Triple Negative Breast Cancer cells and enhances the effectiveness of chemotherapy. ",

author = "SUSAN LOGUE",

year = "2017",

month = jan,

day = "1",

language = "English (Ireland)",

note = " ER Stress, Autophagy \& Immune System. 2017 ; Conference date: 26-01-2017",

}